Ozempic® and the Ivím
weight loss program
A weekly semaglutide shot to improve insulin sensitivity,
reduce appetite, and regulate blood sugar*
*Ozempic ® is not FDA-approved for weight loss. It may be prescribed by an Ivím provider if deemed appropriate for your medical needs. For additional safety information, please see our Safety Page.
Ozempic® (semaglutide) injection is a glucagon-like peptide-1 (GLP-1) receptor agonist originally approved for the treatment of type 2 diabetes. It functions by mimicking a hormone that targets areas of the brain involved in appetite regulation.
Ozempic® works by slowing gastric emptying, enhancing feelings of fullness, and reducing appetite, which can help manage weight when combined with diet and exercise.
Coverage depends on your insurance plan and whether Ozempic is prescribed for an FDA-approved use. Ivím Health offers consultation to navigate insurance or explore self-pay options.
Ivím Health offers weight management programs for patients. Ozempic® is FDA approved for the management of Type 2 Diabetes and may be prescribed by an Ivím Health provider as part of your weight management program.
Choosing a GLP-1 medication like Ozempic® depends on individual health history and insurance coverage. Your Ivím provider can help determine the best option for your weight loss journey.
* Ozempic®is a registered trademark of Novo Nordisk. Ivím is not affiliated with Novo Nordisk.
Real members,
real
results*
*Personal results may vary based on our individualized health programs.
Services
Company
Support
Legal
